Zebularine induces prolonged apoptosis effects via the caspase-3/PARP pathway in head and neck cancer cells

Napso,Tina; Fares,Fuad

doi:10.3892/ijo.2014.2386

Zebularine induces prolonged apoptosis effects via the caspase-3/PARP pathway in head and neck cancer cells

Authors:
- Tina Napso
- Fuad Fares
View Affiliations

Affiliations: Department of Human Biology, Faculty of Natural Sciences, University of Haifa, Mount Carmel, 31905 Haifa, Israel
Published online on: April 11, 2014 https://doi.org/10.3892/ijo.2014.2386
Pages: 1971-1979

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Zebularine, a potent DNA methyltransferase inhibitor, is potentially able to influence gene regulation and thereby alters cell behavior. This study illustrates the effect of zebularine on human squamous cell carcinoma (SCC-9 and SCC-25) in vitro. The results indicated that zebularine significantly (P<0.05) reduced viability and DNA synthesis of treated cancer cells, by induction of cell cycle arrest at G2/M phase and apoptosis in both tested cell lines. This effect was confirmed to be mediated through p21/CHK1- and caspase 3/PARP‑dependent pathways, respectively. However, no methylation was observed in the promoter region of the upregulated p21 and CHK1 genes. This may indicate that the alteration of p21 and CHK1 following zebularine administration was not due to inhibition of methylation of their promoter. Interestingly, it was observed that zebularine continued to influence cell viability for a week following its withdrawal. This may indicate feasibility of novel drug administration strategies, in which, daily administration of the drug replaced by weekly use, leading to improved therapeutic process and cost-effectiveness of the treatment in head and neck cancer.

View Figures

View References

1.	Argiris A, Karamouzis MV, Raben D and Ferris RL: Head and neck cancer. Lancet. 371:1695–1709. 2008. View Article : Google Scholar
2.	Pisani P, Parkin DM and Ferlay J: Estimates of the worldwide mortality from eighteen major cancers in 1985. implications for prevention and projections of future burden. Int J Cancer. 55:891–903. 1993. View Article : Google Scholar : PubMed/NCBI
3.	Perez-Ordonez B, Beauchemin M and Jordan RC: Molecular biology of squamous cell carcinoma of the head and neck. J Clin Pathol. 59:445–453. 2006. View Article : Google Scholar : PubMed/NCBI
4.	Brait M and Sidransky D: Cancer epigenetics: Above and beyond. Toxicol Mech Methods. 21:275–288. 2011. View Article : Google Scholar : PubMed/NCBI
5.	Sharma S, Kelly TK and Jones PA: Epigenetics in cancer. Carcinogenesis. 31:27–36. 2010. View Article : Google Scholar
6.	Laliberte J, Marquez VE and Momparler RL: Potent inhibitors for the deamination of cytosine arabinoside and 5-aza-2′-deoxycytidine by human cytidine deaminase. Cancer Chemother Pharmacol. 30:7–11. 1992.PubMed/NCBI
7.	Cheng JC, Matsen CB, Gonzales FA, et al: Inhibition of DNA methylation and reactivation of silenced genes by zebularine. J Natl Cancer Inst. 95:399–409. 2003. View Article : Google Scholar : PubMed/NCBI
8.	Pompeia C, Hodge DR, Plass C, Wu YZ, Marquez VE, Kelley JA and Farrar WL: Microarray analysis of epigenetic silencing of gene expression in the KAS-6/1 multiple myeloma cell line. Cancer Res. 64:3465–3473. 2004. View Article : Google Scholar : PubMed/NCBI
9.	Billam M, Sobolewski MD and Davidson NE: Effects of a novel DNA methyltransferase inhibitor zebularine on human breast cancer cells. Breast Cancer Res Treat. 120:581–592. 2010. View Article : Google Scholar : PubMed/NCBI
10.	Ben-Kasus T, Ben-Zvi Z, Marquez VE, Kelley JA and Agbaria R: Metabolic activation of zebularine, a novel DNA methylation inhibitor, in human bladder carcinoma cells. Biochem Pharmacol. 70:121–133. 2005. View Article : Google Scholar : PubMed/NCBI
11.	Tan W, Zhou W, Yu HG, Luo HS and Shen L: The DNA methyltransferase inhibitor zebularine induces mitochondria-mediated apoptosis in gastric cancer cells in vitro and in vivo. Biochem Biophys Res Commun. 430:250–255. 2013. View Article : Google Scholar : PubMed/NCBI
12.	You BR and Park WH: Zebularine inhibits the growth of HeLa cervical cancer cells via cell cycle arrest and caspase-dependent apoptosis. Mol Biol Rep. 39:9723–9731. 2012. View Article : Google Scholar : PubMed/NCBI
13.	Suzuki M, Shinohara F, Nishimura K, Echigo S and Rikiishi H: Epigenetic regulation of chemosensitivity to 5-fluorouracil and cisplatin by zebularine in oral squamous cell carcinoma. Int J Oncol. 31:1449–1456. 2007.PubMed/NCBI
14.	Suzuki M, Shinohara F and Rikiishi H: Zebularine-induced reduction in VEGF secretion by HIF-1alpha degradation in oral squamous cell carcinoma. Mol Med Rep. 1:465–471. 2008.PubMed/NCBI
15.	Suzuki M, Shinohara F, Endo M, Sugazaki M, Echigo S and Rikiishi H: Zebularine suppresses the apoptotic potential of 5-fluorouracil via cAMP/PKA/CREB pathway against human oral squamous cell carcinoma cells. Cancer Chemother Pharmacol. 64:223–232. 2009. View Article : Google Scholar : PubMed/NCBI
16.	Brakensiek K, Langer F, Kreipe H and Lehmann U: Absence of p21(CIP 1), p27(KIP 1) and p 57(KIP 2) methylation in MDS and AML. Leuk Res. 29:1357–1360. 2005. View Article : Google Scholar : PubMed/NCBI
17.	Tort F, Hernandez S, Bea S, et al: Checkpoint kinase 1 (CHK1) protein and mRNA expression is downregulated in aggressive variants of human lymphoid neoplasms. Leukemia. 19:112–117. 2005.PubMed/NCBI
18.	Cheng JC, Yoo CB, Weisenberger DJ, et al: Preferential response of cancer cells to zebularine. Cancer Cell. 6:151–158. 2004. View Article : Google Scholar : PubMed/NCBI
19.	You BR and Park WH: Zebularine-induced apoptosis in calu-6 lung cancer cells is influenced by ROS and GSH level changes. Tumour Biol. 34:1145–1153. 2013. View Article : Google Scholar
20.	Teramen H, Tsukuda K, Tanaka N, et al: Aberrant methylation of p21 gene in lung cancer and malignant pleural mesothelioma. Acta Med Okayama. 65:179–184. 2011.PubMed/NCBI